AIM IMMUNOTECH INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
AIM IMMUNOTECH INC. (AIM) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $0 as of 2025-09-30, per its 10-Q filed 2025-11-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2025-11-17
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2024-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $53.40K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed |
|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | |
| 2024-09-30 | $53.40K 10-Q · filed 2025-11-17 | |
| 2024-06-30 | $134.00K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $214.00K 10-Q · filed 2025-05-15 | |
| 2023-09-30 | $35.00K 10-Q · filed 2024-11-14 | |
| 2017-09-30 | $537.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $405.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $135.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $266.00K 10-K · filed 2017-03-31 | |
| 2016-09-30 | $332.00K 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $380.00M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $380.00K 10-Q · filed 2017-08-14 | $168.00M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $199.00K 10-K · filed 2017-03-31 | $199.00M 10-K · filed 2016-03-29 |
| 2015-09-30 | $231.00K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $269.00M 10-Q · filed 2016-08-15 | |
| 2015-03-31 | $200.00M 10-Q · filed 2016-05-16 | |
| 2014-12-31 | $259.00M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |